首页> 外国专利> KAINIC ACID TYPE GLUTAMATE RECEPTOR-SHIELDING AGENT, AMPA TYPE GLUTAMATE RECEPTOR SHIELDING AGENT, BRAIN- PROTECTING AGENT AND FOOD OR DRINK HAVING BRAIN- PROTECTING FUNCTION

KAINIC ACID TYPE GLUTAMATE RECEPTOR-SHIELDING AGENT, AMPA TYPE GLUTAMATE RECEPTOR SHIELDING AGENT, BRAIN- PROTECTING AGENT AND FOOD OR DRINK HAVING BRAIN- PROTECTING FUNCTION

机译:钾酸型谷氨酸受体屏蔽剂,AMPA型谷氨酸受体屏蔽剂,脑保护剂以及具有脑保护功能的食品或饮料

摘要

PROBLEM TO BE SOLVED: To advance researches related to the ingredients of green tea to provide medicines, quasi medicines, foods and drinks which are useful for preventing and treating cerebral diseases and cerebral function disorders.;SOLUTION: A kainic acid type glutamate receptor-shielding agent and an AMPA type glutamate receptor shielding agent each containing theanine as an active ingredient are provided. Since the kainic acid type glutamate receptor and the AMPA type glutamate receptor participate in slowly progressing neurocyte apoptosis among neurocyte apoptosis syndromes, the kainic acid type glutamate receptor-shielding agent and the AMPA type glutamate receptor shielding agent exhibit effects especially for preventing and treating neurodegenerative diseases such as amyotrophic lateral sclerosis. The brain-protecting agent and the brain-protecting function-having food or drink which each contain a mixture of the theanine with catechin as an active ingredient are also provided. When both the theanine and the catechin are administered, remarkably excellent effects can be enjoyed on the prevention and treatment of diseases and cerebral function disorders accompanied by neurocyte apoptosis in comparison with a case that the theanine and the catechin are singly administered, respectively.;COPYRIGHT: (C)2002,JPO
机译:要解决的问题:推进与绿茶成分有关的研究,以提供可用于预防和治疗脑部疾病和脑功能异常的药物,准药物,食品和饮料。;解决方案:一种海藻酸型谷氨酸受体屏蔽剂提供了分别含有茶氨酸作为有效成分的抗氧化剂和AMPA型谷氨酸受体屏蔽剂。由于海藻酸型谷氨酸受体和AMPA型谷氨酸受体参与神经细胞凋亡综合征中缓慢发展的神经细胞凋亡,因此,海藻酸型谷氨酸受体屏蔽剂和AMPA型谷氨酸受体屏蔽剂特别是在预防和治疗神经退行性疾病中具有作用。如肌萎缩性侧索硬化症。还提供了各自含有茶氨酸和儿茶素的混合物作为有效成分的脑保护剂和具有脑保护功能的食物或饮料。当同时施用茶氨酸和儿茶素时,与单独施用茶氨酸和儿茶素的情况相比,在预防和治疗伴有神经细胞凋亡的疾病和脑功能失调方面,可获得非常优异的效果。 :(C)2002,日本特许厅

著录项

  • 公开/公告号JP2002265359A

    专利类型

  • 公开/公告日2002-09-18

    原文格式PDF

  • 申请/专利权人 ITO EN LTD;

    申请/专利号JP20010063970

  • 申请日2001-03-07

  • 分类号A61K31/198;A23L1/30;A61K31/353;A61P25/28;A61P43/00;

  • 国家 JP

  • 入库时间 2022-08-22 01:00:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号